Merck & Co., Inc.

Stocks

MRK

US58933Y1055

Market Closed - NYSE Other stock markets 01:31:54 11/07/2026 am IST			5-day change	1st Jan Change
123.54 ^USD	-1.22%		-4.65%	+17.37%

11/07	Merck Receives Fda Approval for Keytruda and Keytruda Qlex Each with Padcev as Treatment Before and After Surgery for Adults with Muscle-Invasive Bladder Cancer	CI
11/07	Merck, Pfizer, Astellas Bladder Cancer Treatment Approved by FDA	DJ

Transcript : Merck & Co., Inc. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-09-2026 11

Published on 06/09/2026 at 09:50 pm IST - Modified on 06/09/2026 at 11:50 pm IST

S&P Capital IQ

Add MarketScreener to your sources

Presenter Speech
Asad Haider (Analysts)

All right. We're just about at time. So let's keep moving with our next session with Merck. I'm very excited to have Rob Davis, CEO; and Dean Li, EVP Research

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Add MarketScreener to your sources

Latest news about Merck & Co., Inc.

11/07	Merck Receives Fda Approval for Keytruda and Keytruda Qlex Each with Padcev as Treatment Before and After Surgery for Adults with Muscle-Invasive Bladder Cancer	CI
11/07	Merck, Pfizer, Astellas Bladder Cancer Treatment Approved by FDA	DJ
10/07	Biopharma Pricing Power Seen as Key Swing Factor for Q2 Earnings, BofA Says	MT
10/07	Merck's Keytruda Combination Wins Expanded FDA Approval for Muscle Invasive Bladder Cancer	MT
10/07	Berenberg Adjusts Price Target on Merck to $127 From $125, Keeps Hold Rating	MT
09/07	Avacta appoints "seasoned" new deputy chair	AN
09/07	Informa hires former Reuters chief Tom Glocer as chair	AN
08/07	Merck Likely to Post Inline Q2 Revenue, RBC Says	MT
08/07	Morgan Stanley Lifts Price Target on Merck to $113 From $112, Keeps Equalweight Rating	MT
08/07	Wells Fargo Adjusts Price Target on Merck to $150 From $145	MT
07/07	Weight-loss drug developers line up to tap lucrative market as competition heats up	RE
06/07	HSBC Adjusts Price Target on Merck & Co to $150 From $135	MT
06/07	Rothschild & Co Redburn Adjusts Price Target on Merck to $145 From $140	MT
02/07	AbbVie, Other Healthcare Stocks Rise as Trump Administration Reportedly Targets Hospital Drug Markups	MT
01/07	July Opens With a Very Fed-Shaped Cloud